Low serum magnesium levels and metabolic syndrome
Low serum magnesium levels and metabolic syndrome
复制标题
DOI：
10.1007/s005920200036
复制
发表时间：
2002-12-01
影响因子：
3.8
通讯作者：
Rodríguez-Morán, M
中科院分区：
文献类型：
--
作者：
Guerrero-Romero, F;Rodríguez-Morán, M
血清镁水平低与糖尿病（DM）和高血压（HBP）有关，但据我们所知，目前还没有分析代谢综合征（MS）患者血清镁浓度的报道。我们进行了一项基于人群的横断面研究，比较了192名MS患者和384名无疾病对照者，按年龄和性别匹配。排除标准为补充镁治疗和可能引起低镁血症的条件，包括既往诊断为糖尿病（DM）和/或高血压（HBP）。在这方面，只包括糖尿病和高血压的病例。多发性硬化症的定义是至少存在以下两个特征：高血糖（大于或等于7.0 mmol/l）；血压（大于或等于160/90 mmHg）；血脂异常（空腹甘油三酯大于或等于1.7 mmol/l和/或高密度脂蛋白胆固醇）
Low serum magnesium levels are related to diabetes mellitus (DM) and high blood pressure (HBP), but as far as we know, there are no previous reports that analyzed the serum magnesium concentration in individuals with metabolic syndrome (MS). We performed a cross-sectional population-based study to compare 192 individuals with MS and 384 disorder-free control subjects, matched by age and gender. Magnesium supplementation treatment and conditions likely to provoke hypomagnesemia, including previous diagnosis of diabetes mellitus (DM) and/or high blood pressure (HBP), were exclusion criteria. In this regard, only incident cases of DM and HBP were included. MS was defined by the presence at least of two of the following features: hyperglycemia ( greater than or equal to7.0 mmol/l); HBP ( greater than or equal to160/90 mmHg); dyslipidemia (fasting triglycerides greater than or equal to1.7 mmol/l and/or HDL-cholesterol